Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
Saved in:
| Title: | Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance? |
|---|---|
| Authors: | Portal E; Medical Microbiology, Department of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.; Bacteriology Reference Department, Public Health England, London, UK., Descours G; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France., Ginevra C; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France., Mentasti M; Public Health Wales, Cardiff, UK., Afshar B; Bacteriology Reference Department, Public Health England, London, UK., Chand M; Bacteriology Reference Department, Public Health England, London, UK., Day J; Bacteriology Reference Department, Public Health England, London, UK., Echahidi F; Department of Microbiology and Infection Control, National Reference Centre for Legionella pneumophila, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium., Franzin L; Ospedale Amedeo di Savoia, Torino, Italy., Gaia V; Department of Laboratory Medicine, Reference Centre for Legionella, Bellinzona, Switzerland., Lück C; German Consiliary Laboratory for Legionella, Institute of Medical Microbiology and Hygiene, Dresden University of Technology, Dresden, Germany., Meghraoui A; Department of Microbiology, National Reference Centre for Legionella pneumophila, Laboratoire Hospitalier Universitaire de Bruxelles-University Laboratory of Brussels (LHUB-ULB), Belgium., Moran-Gilad J; Department of Health Systems Management, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel., Ricci ML; National Institute for Health, Rome, Italy., Lina G; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France., Uldum S; Statens Serum Institute, Copenhagen, Denmark., Winchell J; National Center for Immunization and Respiratory Diseases, Centres for Disease Control and Prevention, Atlanta, GA, USA., Howe R; Public Health Wales, Cardiff, UK., Bernard K; Special Bacteriology Unit, National Microbiology Laboratory-PHAC, Winnipeg, Canada., Spiller OB; Medical Microbiology, Department of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK., Chalker VJ; Bacteriology Reference Department, Public Health England, London, UK.; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Respiratory Infections at Imperial College London in partnership with Public Health England (PHE), London, UK., Jarraud S; Centre National de Reference des Legionelles, Hospices Civils de Lyon, University de Lyon, Lyon, France. |
| Corporate Authors: | ESCMID Study Group for Legionella Infections (ESGLI) |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Apr 13; Vol. 76 (5), pp. 1113-1116. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2091 |
|---|---|
| DOI: | 10.1093/jac/dkab027 |
